Cetirizine Hydrochloride + Phenylephrine HydrochlorideThird Party Manufacturing in India

This fixed-dose combination provides dual-action symptomatic relief for upper respiratory allergies by pairing an antihistamine with a nasal decongestant.

Cetirizine Hydrochloride acts as a selective, long-acting peripheral H1 receptor antagonist. It competitively blocks histamine from binding to H1 receptors on vascular endothelium, respiratory smooth muscle, and immune cells. This prevents histamine-mediated effects including vasodilation, increased capillary permeability, and the characteristic symptoms of sneezing, rhinorrhea, nasal itching, and ocular irritation. Due to its polar structure, cetirizine does not readily cross the blood-brain barrier, resulting in minimal central nervous system sedation compared to first-generation antihistamines.

Phenylephrine Hydrochloride is a selective alpha-1 adrenergic receptor agonist. It acts directly on alpha-1 receptors located on the smooth muscle of capacitance blood vessels in the nasal mucosa. This stimulation causes vasoconstriction, which reduces blood flow to the nasal tissues, shrinks swollen mucous membranes, and opens nasal passages. The decongestant effect of phenylephrine provides rapid relief from nasal congestion and blockage. By combining these two mechanisms, the product simultaneously addresses the allergic symptoms mediated by histamine release and the nasal congestion caused by inflammatory vasodilation, offering comprehensive symptom relief in a single dose.

This combination is prescribed for the treatment of:

• Allergic Rhinitis with Nasal Congestion: Provides comprehensive relief of sneezing, runny nose, nasal itching, and nasal blockage in both seasonal and perennial allergic rhinitis.
• Common Cold: Used for symptomatic relief of cold symptoms including rhinorrhea, sneezing, and nasal congestion.
• Sinusitis: Helps relieve nasal congestion and promote drainage of the sinuses.
• Eustachian Tube Dysfunction: Addresses congestion-related ear pressure and discomfort associated with upper respiratory allergies.

Why Manufacturers Choose This Combination

The cetirizine plus phenylephrine combination is a first-line treatment for allergic rhinitis with nasal congestion, one of the most common respiratory conditions encountered in clinical practice. The syrup formulation is particularly popular in pediatric and geriatric patients who have difficulty swallowing tablets. Indian pharmaceutical companies have strong demand for this combination across both domestic PCD franchise networks and export markets in Africa, Asia, and the Middle East. Both active ingredients are cost-effective and readily available from domestic API manufacturers.

This makes Cetirizine + Phenylephrine a reliable product for third party manufacturing in India, with consistent prescription demand across both retail and hospital channels.